Showing posts with label AS. Show all posts
Showing posts with label AS. Show all posts

Treating ankylosing spondylitis Part 2

Tumour necrosis factor (TNF) blocker

If your symptoms cannot be controlled using painkillers or exercising and stretching, a tumour necrosis factor (TNF) blocker may be recommended. TNF is a chemical produced by cells when tissue is inflamed.
TNF blockers are given by injection and work by preventing the effects of TNF. This helps reduce inflammation in your joints caused by ankylosing spondylitis. Examples of TNF blockers include:

  • Adalimumab
  • Etanercept
  • Golimumab

TNF alpha blockers are a relatively new form of treatment for ankylosing spondylitis, and their long-term effects are unknown. However, research into the use of TNF blockers for treating rheumatoid arthritis is providing clearer information about their long-term safety.
If your rheumatologist recommends using TNF blockers, the decision about whether they are right for you must be discussed carefully and your progress will be closely monitored. This is because TNF blockers interfere with the immune system (the body’s natural defence system).

NICE guidelines

The National Institute for Health and Clinical Excellence (NICE) has produced guidance about the use of these TNF blockers. NICE states that adalimumab, etanercept and golimumab may only be used if:

  • Your diagnosis of ankylosing spondylitis has been confirmed
  • Your level of pain is assessed twice (using a simple scale that you fill in) 12 weeks apart and confirms your condition is still active (has not improved)
  • Your Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is tested twice, 12 weeks apart, and confirms your condition is still active (BASDAI is a set of measures devised by experts to evaluate your condition by asking a number of questions about your symptoms)
  • Treatment with two or more NSAIDs for four weeks at the highest possible dose has not controlled your symptoms

After 12 weeks of treatment with TNF blockers, your pain score and BASDAI will be tested again to see whether they have improved sufficiently to make continued treatment worthwhile for you. If they have, treatment will continue and you will be tested every 12 weeks.
If there is not enough improvement after 12 weeks, you will be tested again at a later date or the treatment will be stopped.
Infliximab is an alternative TNF blocker that may be used to treat ankylosing spondylitis. However, it is not recommended by NICE. If you are currently taking infliximab, you should continue to do so until you and your rheumatologist decide it is appropriate for you to stop.
Other new TNF blockers and similar medications are being developed and may be approved by NICE.

Bisphosphonates

Bisphosphonates are usually used to treat osteoporosis (weak and brittle bones), which can sometimes develop as a complication of ankylosing spondylitis. Bisphosphonates may also be effective in treating ankylosing spondylitis, although the evidence is not entirely clear. They may also be used if you have osteoporosis.
Bisphosphonates can be taken by mouth (orally) as tablets or given by injection.

Disease-modifying anti-rheumatic drugs (DMARDs)

Disease-modifying anti-rheumatic drugs (DMARDs) are an alternative type of medication often used to treat other types of arthritis. DMARDs may be prescribed for ankylosing spondylitis, although they are only beneficial if peripheral joints are involved rather than the spine.
Two DMARDs found helpful for inflammation of joints other than the spine include:

  • Sulfasalazine
  • Methotrexate


Corticosteroids

Corticosteroid medicines (steroids) have a powerful anti-inflammatory effect and can be taken in various ways, for example as:

  • Tablets (oral)
  • Injections (parenteral)


If a particular joint is inflamed, corticosteroids can be injected directly into the joint. After the injection you will need to rest the joint for up to 48 hours (two days). It is usually considered wise to have a corticosteroid injection up to three times in one year, with at least three months between injections in the same joint. This is because corticosteroids injections can cause a number of side effects, such as:

  • Infection in response to the injection
  • The skin around the injection may change colour (depigmentation)
  • The surrounding tissue may waste away
  • A tendon (cord of tissue that connects muscles to bones) near the joint may rupture (burst)

Corticosteroids may also help to calm down painful swollen joints when taken as tablets. Occasionally, when pain and stiffness are severe, corticosteroids can be very helpful when given as an injection into your muscle (intramuscular injection).

Ankylosing spondylitis (AS)

Ankylosing spondylitis (AS) is a type of chronic (long-term) arthritis that affects parts of the spine, including bones, muscles and ligaments.
Arthritis is a common condition that causes pain and inflammation of the joints and tissues around them.
The symptoms of ankylosing spondylitis can vary, but most people experience back pain and stiffness. The condition can be severe, with around one in 10 people at risk of long-term disability.

What causes ankylosing spondylitis?

In ankylosing spondylitis, the spinal joints, ligaments and the sacroiliac joints (the joints at the base of the spine) become inflamed. This inflammation causes pain and stiffness in the neck and back. Sacroiliitis (inflammation of the sacroiliac joints) leads to pain in the lower back and buttocks.
It is not known what causes the condition, but there is thought to be a link with a particular gene known as HLA-B27.

Treating ankylosing spondylitis

There is no cure for ankylosing spondylitis. The aim of treatment is to ease the pain and stiffness and to keep the spine flexible. Treatment includes:

  • Physiotherapy – where physical methods, such as massage and manipulation, are used to improve comfort and spinal flexibility (only the muscles and soft tissue should be manipulated and never the bones of the spine – manipulating bones in people with ankylosing spondylitis can cause injury)
  • Medication – helps relieve pain and control symptoms
  • Lifestyle changes – to minimise the risk of other health conditions and improve symptoms

Complications

Inflammation of part of the eye (uveitis) is sometimes associated with ankylosing spondylitis. If you have ankylosing spondylitis and develop pain or redness in one of your eyes, you should urgently see your GP as it can lead to loss of vision.  
In advanced cases of ankylosing spondylitis, the pain and stiffness can lead to your posture becoming fixed in one position.

Who is affected?

Ankylosing spondylitis can develop at any time from teenage years onwards, although it usually occurs between 15 and 35 years of age and rarely starts in old age. It is around three times more common in men than in women.

Further info on the treatment of AS can be found HERE
Copyright © Stop My Backache - British Heart Foundation - Sponsored by ukscootersales.com